Dec. 30, 2021
Maintaining Security and Confidentiality in NIH Peer Review: Rules, Responsibilities and Possible Consequences - See NOT-OD-22-044
Oct. 18, 2021
Notice of Clarification of Institutional Responsibilities Regarding NIH Grant to Protocol Congruence Review - See NOT-OD-22-005
Feb. 8, 2021
Notice of Changes in the Review Criteria for Applications Submitted for NIH Support for Scientific Conferences (R13 and U13) - for the April 12, 2021 application due date and beyond - See NOT-OD-21-055
Oct. 23, 2020
Notice of Clarification: Policy for Managing Conflict of Interest in NIH Peer Review - See NOT-OD-21-019
Oct. 16, 2020
Notice of Policy Revision: Managing Conflicts of Interest for Requests for Applications (RFAs) - See NOT-OD-21-005
June 9, 2020
Coronavirus Update: Additional Guidance for Peer Reviewers - for August-October 2020 Councils
April 17, 2020
Coronavirus Update: Guidance for Peer Reviewers - for applications in for review during the coronavirus pandemic national emergency
NOTE: The announcements below all apply to applications submitted for due dates on or after January 25, 2019:
January 2, 2019
Implementation of the Final Rule on Federal Policy for the Protection of Human Subjects (Common Rule). NIH will transition from “E” to “X” codes to reflect categories of exempt research. See NOT-OD-19-050.
September 14, 2018
Updates to Review Criteria for Fellowship Applications. NIH will update review language for fellowship applications. See NOT-OD-18-227.
Updates to Review Criteria for Research Grant Applications. NIH will update review language for research projects. See NOT-OD-18-228.
Updates to Review Criteria for Career Development Award Applications. NIH will update review language for most career development award applications submitted for due dates on or after January 25, 2019. See NOT-OD-18-229.
December 19, 2017
NIH Policy on the Inclusion of Individuals Across the Lifespan as Research Participants. NIH review groups will assess each application /proposal as “acceptable” or “unacceptable” with regard to the age-appropriate inclusion or exclusion of individuals in the research project. See NOT-OD-18-116.
NOTE: The announcements below apply to applications submitted for due dates on or after January 25, 2018.
December 1. 2017
Additional Review Criteria for Career Development Award Applications Involving Clinical Trials. NIH will apply additional review criteria for career development award applications involving clinical trials. See NOT-OD-18-109.
October 6, 2017
Additional Review Criteria for NRSA Individual Fellowship Applications. NIH will apply additional review criteria for NRSA individual fellowships proposing to gain research experience in an ongoing clinical trial led by a sponsor or co-sponsor. See NOT-OD-17-122.
Additional Review Criteria for NRSA Institutional Fellowship Applications. NIH will apply additional review criteria for NRSA institutional fellowships proposing to gain research experience in an ongoing clinical trial led by a mentor or co-mentor. See NOT-OD-17-123.
Thursday, September 21, 2017
Thursday, August 17, 2017
Clinical Trial Requirements for Grants and Contracts. NIH is launching a series of initiatives that are rolling out in 2017-2018 to enhance the accountability and transparency of clinical research. Learn more about these changes and how they will affect peer review. See the Clinical Trials webpage.
Thursday, August 17, 2017
Updated Appendix Policy Eliminates Clinical Trial-Related Materials for Applications Submitted to Due Dates on or After Jan. 25, 2018. Since clinical trial-related materials will be required in the new PHS Human Subjects and Clinical Trials Information Form, they will no longer be allowed in the Appendix for due dates on or after January 25, 2018, unless specifically required in the funding opportunity announcement. See NOT-OD-17-098.
NOTE: The announcement below applies to applications submitted for due dates on or after September 25, 2017.
May 30, 2017
Additional Change to the NIH/AHRQ/NIOSH Policy on Post-Submission Materials. The NIH will accept citations to issued patents as allowable post-submission materials. See NOT-OD-17-066.